KARRI BERLIN: Open Payments
NPI 1619521606 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,891 in 99 payments from 17 companies in 2025. Trend: 2023 $1,271 · 2024 $1,665 · 2025 $1,891
Food & beverage: $1,891
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $646 |
| Janssen Biotech, Inc. | 9 | $190 |
| Ardelyx, Inc. | 12 | $178 |
| Regeneron Healthcare Solutions, Inc. | 7 | $158 |
| Novo Nordisk Inc | 6 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $97 |
| Celltrion USA Inc. | 4 | $90 |
| GENZYME CORPORATION | 3 | $74 |
| Madrigal Pharmaceuticals | 4 | $66 |
Products named: RINVOQ, DUPIXENT, TREMFYA, IBSRELA, Wegovy, CREON, XIFAXAN, VEGZELMA.
Industry payments across KY — which companies pay providers there.
